TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT01278953
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT01278953
-
- Other papers using this trial's data
- Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01278953. Randomized; single masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2013-06 (actual). Results posted on 2016-02-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation
- Acronym
- TOCCASTAR
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Catheter ablation to treat paroxysmal atrial fibrillation
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01278953- Content hash
1f4829b85dd792b6773f73dd1f4db8c1307f7f63880015611c520745e0252e89